Modulating Autophagy to Eradicate HIV-1 from CNS Reservoirs
调节自噬以消除中枢神经系统储库中的 HIV-1
基本信息
- 批准号:9261606
- 负责人:
- 金额:$ 38.37万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-05-01 至 2019-04-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAmyloidAnti-Retroviral AgentsApplications GrantsAstrocytesAutophagocytosisBiological ModelsBiological PreservationBlood CirculationBone Marrow TransplantationBrainCD4 Positive T LymphocytesCellsClinicalCommunicable DiseasesComplicationDataDown-RegulationGoalsHIVHIV InfectionsHIV-1ImmuneImpaired cognitionIn VitroInfectionKnowledgeLaboratoriesMicrogliaMinorModelingMolecularMusMyelogenousNebraskaNeuraxisNeurocognitive DeficitNeuronsOutcomePathogenesisPathway interactionsPatientsPeptidesPeripheralPersonsPhagocytosisPharmacologyPlayPopulationPropertyResearchResearch PersonnelRestRiskRoleSignal TransductionSiteT-LymphocyteTestingToxic effectTranslatingUniversitiesViralViral reservoirVirusVirus Diseasesantiretroviral therapybasecell typeefficacy testingexperimental studyhumanized mouseimmune functionimprovedin vivoinnovationkillingslymph nodesmacrophagemouse modelnanoneuroAIDSneuroinflammationneurotoxicitynovelnovel strategiespreventpublic health relevancetargeted treatmentvirology
项目摘要
DESCRIPTION (provided by applicant): Although combination antiretroviral therapy has led to significant virologic suppression and improvement in immune function, neurocognitive impairment remains an important clinical complication of HIV infection. In fact, some have suggested that antiretroviral treatment might enhance the risk of minor cognitive impairment through the disruption of microglial phagocytosis of �-amyloid. Moreover, although there has been a single documented case of a HIV cure in a patient following bone marrow transplantation, no effective strategy has been developed that can leads to eradication of virus. In the research proposed, we will examine the role of autophagy in the preservation of HIV reservoirs within the central nervous system (CNS) and identify strategies to eradicate virus from these occult sites. This research will build upon our considerable preliminary data that has established autophagy as an important mechanism of HIV pathogenesis and that modulation of autophagy can inhibit HIV and preferentially kill HIV infected cells. The Specific Aims of this proposal are: Aim 1: Identification of role of HIV in the modulation of autophagy in infected microglia and astrocytes; Aim 2: Eradication of HIV from macrophages, microglial cells and astrocytes through the induction of autophagy and killing of HIV and/or preferential killing of HIV-infected cells; Aim 3: In vitro optimization of HIV eradication in target cells within the CNS resulting in the least toxicity to neurons; Aim 4: Eradication of HIV from resting T- cells through
the induction of autophagy and preferential killing of HIV-infected cells; and Aim 5: In vivo eradication of HIV through the induction of autophagy combined with long-acting nano-formulated antiretroviral therapy (nanoART) in a humanized NSG mouse brain model of HIV. There are many innovative aspects to this grant proposal. First, the strategy of modulating autophagy to kill HIV and HIV-infected cells is innovative and has been pioneered by my laboratory. Second, in addition to using pharmacologic agents to induce autophagy through different pathways, we will use an innovative tat-Beclin 1 peptide that effectively enters cells an leads to the killing of HIV. Third, we will translate our in vitro findings into a novel and innovaive mouse model system to test our findings in vivo and combine our approach with the use of nano-ART to improve antiretroviral delivery to cells. Fourth, we have established an outstanding team of investigators to combine their considerable knowledge of HIV, macrophages, autophagy and NeuroAIDS in order to address this challenging problem. Finally, this innovative approach provides a novel strategy to eradicate HIV from the CNS as well as the rest of the body that if successful has the potential to be applied to all HIV-infected persons.
描述(由申请人提供):尽管抗逆转录病毒联合治疗导致了显著的病毒学抑制和免疫功能的改善,但神经认知障碍仍然是HIV感染的重要临床并发症。事实上,一些人认为抗逆转录病毒治疗可能会通过破坏-淀粉样蛋白的小胶质细胞吞噬而增加轻度认知障碍的风险。此外,尽管有一例记录在案的患者在骨髓移植后治愈了艾滋病毒,但尚未制定出能够导致根除病毒的有效策略。在本研究中,我们将研究自噬在保存中枢神经系统(CNS)内HIV储存库中的作用,并确定从这些隐匿部位根除病毒的策略。本研究将建立在我们大量的初步数据基础上,这些数据已经确定自噬是HIV发病的重要机制,并且调节自噬可以抑制HIV并优先杀死HIV感染的细胞。本提案的具体目的是:目的1:确定HIV在受感染的小胶质细胞和星形胶质细胞自噬调节中的作用;目标2:通过诱导自噬和杀死艾滋病毒和/或优先杀死感染艾滋病毒的细胞,从巨噬细胞、小胶质细胞和星形胶质细胞中根除艾滋病毒;目的3:体外优化在中枢神经系统内靶细胞中根除HIV,使其对神经元的毒性最小;目标4:从静止的T细胞中根除HIV
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
STEPHEN A SPECTOR其他文献
STEPHEN A SPECTOR的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('STEPHEN A SPECTOR', 18)}}的其他基金
HIV CENTERS FOR UNDEREPRESENTED POPULATIONS IN RESEARCH CTU (HIV CURE CTU) Administrative Supplement
CTU 弱势群体艾滋病毒研究中心 (HIV CURE CTU) 行政补充
- 批准号:
10166548 - 财政年份:2020
- 资助金额:
$ 38.37万 - 项目类别:
Modulating Autophagy to Eradicate HIV-1 from CNS Reservoirs
调节自噬以消除中枢神经系统储库中的 HIV-1
- 批准号:
8656828 - 财政年份:2013
- 资助金额:
$ 38.37万 - 项目类别:
Modulating Autophagy to Eradicate HIV-1 from CNS Reservoirs
调节自噬以消除中枢神经系统储库中的 HIV-1
- 批准号:
8543335 - 财政年份:2013
- 资助金额:
$ 38.37万 - 项目类别:
Host Genetic Factors Associated with CNS Disease of HIV-Infected Children
与艾滋病毒感染儿童中枢神经系统疾病相关的宿主遗传因素
- 批准号:
8641735 - 财政年份:2011
- 资助金额:
$ 38.37万 - 项目类别:
Host Genetic Factors Associated with CNS Disease of HIV-Infected Children
与艾滋病毒感染儿童中枢神经系统疾病相关的宿主遗传因素
- 批准号:
8448656 - 财政年份:2011
- 资助金额:
$ 38.37万 - 项目类别:
Host Genetic Factors Associated with CNS Disease of HIV-Infected Children
与艾滋病毒感染儿童中枢神经系统疾病相关的宿主遗传因素
- 批准号:
8209570 - 财政年份:2011
- 资助金额:
$ 38.37万 - 项目类别:
Host Genetic Factors Associated with CNS Disease of HIV-Infected Children
与艾滋病毒感染儿童中枢神经系统疾病相关的宿主遗传因素
- 批准号:
8307769 - 财政年份:2011
- 资助金额:
$ 38.37万 - 项目类别:
Vitamin D Inhibition of HIV and M. Tuberculosis Coinfection in Macrophages
维生素 D 对巨噬细胞中 HIV 和结核分枝杆菌混合感染的抑制作用
- 批准号:
7755309 - 财政年份:2009
- 资助金额:
$ 38.37万 - 项目类别:
ADOLESCENT MASTER PROTOCOL (AMP) - IMPACT OF HIV AND ART ON GROWTH
青少年主方案 (AMP) - 艾滋病毒和艺术对成长的影响
- 批准号:
8166833 - 财政年份:2009
- 资助金额:
$ 38.37万 - 项目类别:
相似国自然基金
基于聚金属氧酸盐对Amyloid蛋白的定点化学修饰及其在阿尔茨海默症治疗中的应用
- 批准号:
- 批准年份:2020
- 资助金额:63 万元
- 项目类别:面上项目
基于S1P通路探究Amyloid-β在干性年龄相关性黄斑变性中的作用
- 批准号:81870666
- 批准年份:2018
- 资助金额:57.0 万元
- 项目类别:面上项目
Amyloid-beta-PirB 相互作用介导小胶质细胞表型和功能变化参与AD进展的机制研究
- 批准号:81601123
- 批准年份:2016
- 资助金额:17.0 万元
- 项目类别:青年科学基金项目
Beta-amyloid寡聚体特有的抗原表位多肽疫苗的研究
- 批准号:30971012
- 批准年份:2009
- 资助金额:35.0 万元
- 项目类别:面上项目
抗阿兹海默病Beta-Amyloid寡聚物单链可变区抗体的筛选及其动物试验
- 批准号:30570622
- 批准年份:2005
- 资助金额:30.0 万元
- 项目类别:面上项目
相似海外基金
Elucidating the function of a protective protein in a novel in vitro reconstitution system for disaggregation of ubiquitinated amyloid fibrils
阐明保护蛋白在新型体外重构系统中用于解聚泛素化淀粉样蛋白原纤维的功能
- 批准号:
24K10522 - 财政年份:2024
- 资助金额:
$ 38.37万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
新規amyloid-β抑制因子ILEIの減少に伴うアルツハイマー病リスクと分子制御機構の解析
新型β淀粉样蛋白抑制剂ILEI降低相关阿尔茨海默病风险及分子调控机制分析
- 批准号:
23K06805 - 财政年份:2023
- 资助金额:
$ 38.37万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Extracting the detrimental effects of amyloid beta oligomer using contextual learning and controlling it with antagonist molecules
使用情境学习提取β淀粉样蛋白寡聚体的有害影响并用拮抗剂分子控制它
- 批准号:
23K06348 - 财政年份:2023
- 资助金额:
$ 38.37万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Project 3: 3-D Molecular Atlas of cerebral amyloid angiopathy in the aging brain with and without co-pathology
项目 3:有或没有共同病理的衰老大脑中脑淀粉样血管病的 3-D 分子图谱
- 批准号:
10555899 - 财政年份:2023
- 资助金额:
$ 38.37万 - 项目类别:
Development of inhibitors for amyloid peptide aggregation based on peptidomimetics
基于拟肽的淀粉样肽聚集抑制剂的开发
- 批准号:
23K14318 - 财政年份:2023
- 资助金额:
$ 38.37万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Effect of abnormal beta-amyloid on Ca dynamics in neural cells
异常β-淀粉样蛋白对神经细胞钙动力学的影响
- 批准号:
23K14744 - 财政年份:2023
- 资助金额:
$ 38.37万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of novel functions of presenilin in ApoE secretion and brain amyloid removal
阐明早老素在 ApoE 分泌和脑淀粉样蛋白去除中的新功能
- 批准号:
23KF0156 - 财政年份:2023
- 资助金额:
$ 38.37万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Mechanisms underlying Sex differences in Cerebral Amyloid Angiopathy: The Fibrin-Microglia Crosstalk
脑淀粉样血管病性别差异的潜在机制:纤维蛋白-小胶质细胞串扰
- 批准号:
10662862 - 财政年份:2023
- 资助金额:
$ 38.37万 - 项目类别:
Probing Amyloid Fibril Self-Assembly with Network Hamiltonian Simulations in Explicit Space
用显式空间中的网络哈密顿模拟探测淀粉样蛋白原纤维的自组装
- 批准号:
10715891 - 财政年份:2023
- 资助金额:
$ 38.37万 - 项目类别:
Astrocytic exocytosis of ATP in amyloid pathology and Alzheimer's disease
淀粉样蛋白病理学和阿尔茨海默病中 ATP 的星形细胞胞吐作用
- 批准号:
10722422 - 财政年份:2023
- 资助金额:
$ 38.37万 - 项目类别:














{{item.name}}会员




